The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD ( GOLD) - why and what?
- Published in:
- Clinical Respiratory Journal, 2012, v. 6, n. 4, p. 208, doi. 10.1111/crj.12002
- By:
- Publication type:
- Article
Works matching IS 17526981 AND DT 2012 AND VI 6 AND IP 4
Results: 6
1
2
Omalizumab in patients with severe asthma: the XCLUSIVE study.
- Published in:
- Clinical Respiratory Journal, 2012, v. 6, n. 4, p. 215, doi. 10.1111/j.1752-699X.2011.00263.x
- By:
- Publication type:
- Article
3
Efficacy and safety of the long-acting muscarinic antagonist GSK233705 delivered once daily in patients with COPD.
- Published in:
- Clinical Respiratory Journal, 2012, v. 6, n. 4, p. 248, doi. 10.1111/j.1752-699X.2011.00278.x
- By:
- Publication type:
- Article
4
Clinical aspects of using exhaled NO in asthma diagnosis and management.
- Published in:
- Clinical Respiratory Journal, 2012, v. 6, n. 4, p. 193, doi. 10.1111/crj.12001
- By:
- Publication type:
- Article
5
A study of asthma severity in adult twins.
- Published in:
- Clinical Respiratory Journal, 2012, v. 6, n. 4, p. 228, doi. 10.1111/j.1752-699X.2011.00273.x
- By:
- Publication type:
- Article
6
Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
- Published in:
- Clinical Respiratory Journal, 2012, v. 6, n. 4, p. 238, doi. 10.1111/j.1752-699X.2011.00276.x
- By:
- Publication type:
- Article